Latife Meral KAYIKÇIOĞLU
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Anabilim Dalı
Research areas: Health Sciences, Medicine, Internal Medicine Sciences, Cardiovascular, Fundamental Medical Sciences, Internal Diseases, Natural Sciences, Life Sciences, Nephrology, Biochemistry
Publications
- Sex-specific differences in cardiovascular risk factors and their management (2026)
- Caffeine and Cardiometabolic Health: Evidence, Controversies, and Clinical Considerations (2026)
- Sex differences and gender-related factors in the management and perception of LDL-cholesterol in ASCVD: Real-Life evidence from the EPHESUS registry in cardiology practice (2026)
- Awareness of Cardiovascular Disease as the Primary Cause of Mortality in Women: Insights from a Survey of 7,920 Individuals (2026)
- Lipoprotein(a) and Aortic Stenosis: From Genetic Risk to Emerging Therapeutic Strategies (2026)
- Reply to the Letter to the Editor: Cumulative LDL-C and Lipoprotein(a) in Elderly Patients with Hyperlipidemia: Methodological Considerations and Clinical Implications (2026)
- PULMONER ARTERİYEL HİPERTANSİYONDA YAVAŞ TEMPOLU SOLUNUMUN HASTA SONUÇLARINA ETKİSİ (2025)
- Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition (2025)
- Proposed lipidology and preventive cardiology research priorities in Africa; Results of a Delphi survey (2025)
- Making the invisible visible: Leveraging electronic health records to uncover familial hypercholesterolemia in primary care (2025)
- Barriers to lipid lowering therapy in Turkiye: Patient’s perspective (B-Aware dyslipidemia) (2025)
- The Hidden Burden of Premature Cardiovascular Disease in a National Leader: Mustafa Kemal Atatürk’s Familial Risk, Lifestyle, and Occupational Stress (2025)
- From universal screening to child–parent cascade: A family-centered approach to Familial hypercholesterolemia prevention (2025)
- Impact of Evinacumab on coronary plaques in patients with Homozygous Familial Hypercholesterolemia: Protocol of the "EVOLVE-HoFH" study (EValuation of atherOma pLaque Volume after Evinacumab in HOmozygous Familial Hypercholesterolemia) (2025)
- Inadequate awareness and attention to non-HDL cholesterol: undertreatment of high-risk patients in cardiology practice in Turkey (2025)
- Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial (2025)
- Which biomarkers predict risk better in women? (2025)
- Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN (2024)
- Bridging the Gap: Insights from the AIZANOI Study on Low-Density Lipoprotein-Cholesterol Management in Türkiye (2024)
- Atherosclerosis associated with Chlamydia pneumoniae: Dissecting the etiology (2024)
- Turk-heart: A study designed to determine strategies for achieving recommended dyslipidemia treatment goals in very high CVD risk patients in Turkey (2024)
- Evaluation of 2-year cardiovascular outcomes in patients with early acute coronary syndrome: Real-life data from a retrospective cohort (2024)
- Is There a Need for Sex‐Tailored Lipoprotein(a) Cut‐Off Values for Coronary Artery Disease Risk Stratification? (2024)
- Baseline Characteristics and Clinical Insights from the ARTEMIS Registry: A Comprehensive Study of Peripartum Cardiomyopathy in Türkiye (2024)
- Ferroptosis: A novel paradigm in the pathophysiology of MINOCA (2024)
- Penicillin/gentamicin vs ampicillin/sulbactam/gentamicin vs vancomycin/gentamicin in the empirical therapy of native valve infective endocarditis (2024)
- Infective endocarditis in a developing country: evaluation of 230 cases (2024)
- Assessment of dyslipidemia management in Turkey using a Delphi panel (2024)
- Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry (2024)
- Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPN (2023)
- Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension (2023)
- Case report: Therapy adherence, MTTP variants, and course of atheroma in two patients with HoFH on low-dose, long-term lomitapide therapy (2023)
- Could Heart Rate Variability Serve as a Prognostic Factor in Patients with Pulmonary Hypertension? A Single-center Pilot Study (2023)
- Dyslipidemia prevalence in nonobese, nondiabetic patients with obstructive sleep apnea: does sex matter? (2023)
- CARDIOVASCULAR DISEASE IS THE LEADING CAUSE OF MORTALITY IN WOMEN, ARE WE AWARE? A SURVEY STUDY ON 7920 INDIVIDUALS. (2023)
- Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis (2023)
- Are we seeing the light at the end of the tunnel for high lipoprotein(a)? Lipoprotein(a) (2023)
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance (2023)
- Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database (2023)
- Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society (2023)
- Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial (2023)
- Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry (2023)
- Evaluation of Clinical Features including the frequency of Familial Hypercholesterolemia, and 2-Year Cardiovascular Outcomes in Patients with Early Acute Coronary Syndrome: Real-Life Data from a Retrospective Cohort (2023)
- Editorial. (2023)
- Evaluation of the Effectiveness of Individually Tailored Lifestyle Intervention in Patients With Familial Hypercholesterolemia (2022)
- How to Generate Unbiased Data in Molecular Genetic Studies in Patients with Early Onset Coronary Artery Disease or Premature Myocardial Infarction? (2022)
- Current Treatment Options in Homozygous Familial Hypercholesterolemia (2022)
- Relationship Between Work Mode, Time of Admission, and Mortality in St-Segment Elevation Myocardial Infarction: Results From the TURKMI Registry (2022)
- Primary Carnitine Deficiency as a Treatable Cause of Heart Failure in Young Patients (2022)
- Two Case Reports of Progressive Pulmonary Hypertension with Type-1 Gaucher Disease: Efficient PAH-Specific Therapy and 1-Year Follow-Up (2022)
- Clinical Presentation and Outcomes in Real-Life Management of Elderly Patients Aged ≥75 Years Presenting with Acute Myocardial Infarction (2022)
- Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases (2022)
- Evaluation of the Effectiveness of Individually Tailored Lifestyle Intervention in Patients With Familial Hypercholesterolemia (2022)
- Gender differences in applicability of guidelines in clinical practice of heart failure patients (2021)
- Knowledge and attitudes towards hypertriglyceridaemia and associated residual risk amongst cardiologists in Turkey (2021)
- Assessment of awareness of risk factors and heart healthy lifestyle as a part of routine cardiovascular evaluation in secondary prevention (2021)
- Premature Myocardial Infarction: A Rising Threat (2021)
- Gender differences in applicability of guidelines in clinical practice of heart failure patients (2021)
- 691. Infective Endocarditis with an Indication for Cardiac Surgery in a Tertiary Care Educational Hospital: Does Cardiac Surgery Improve Outcomes? (2021)
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021)
- Hepatic and splenic sonographic and sonoelastographic findings in pulmonary arterial hypertension (2021)
- Recommendations for Ramadan fasting to patients with cardiovascular diseases; Turkish Society of Cardiology consensus report (2021)
- Claims-based Frailty indices may function as long-term risk estimates for elderly patients after hospitalization (2021)
- Management of LDL‐cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real‐life evidence of Under‐treatment from the EPHESUS registry (2021)
- Familial Hypercholesterolemia: Global Burden and Approaches (2021)
- Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry (2021)
- Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia (2021)
- Telemedicine in Cardiology Outpatient Clinic: First Experience from a Tertiary Medical Center During the COVID-19 Pandemic (2021)
- Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea? (2021)
- LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective (2021)
- The landscape of preventive cardiology in Turkey: Challenges and successes (2021)
- Can serum 8-hydroxy-2'-deoxyguanosine levels reflect the severity of pulmonary arterial hypertension? (2021)
- Impact of the COVID-19 pandemic in patients with a previous history of premature myocardial infarction (2020)
- Treatment Delays and In-Hospital Outcomes in Acute Myocardial Infarction During the COVID-19 Pandemic: A Nationwide Study (2020)
- The role of cholesteryl ester transfer protein TaqIB polymorphism in young atherosclerotic heart disease (2020)
- Right ventricular function in patients with pulmonary arterial hypertension associated with congenital heart disease with repaired and unrepaired defects correlation of speckle tracking, conventional echocardiography and clinical parameters (2020)
- Monozygotic twins with familial hypercholesterolemia and high Lipoprotein(a) levels leading to identical cardiovascular outcomes: case report and review of the literature (2020)
- Short and Midterm Outcomes in Patients With Acute Myocardial Infarction: Results of the Nationwide TURKMI Registry (2020)
- Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia (2020)
- Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic (2020)
- Hepatic and splenic sonographic and sonoelastographic findings in pulmonary arterial hypertension (2020)
- KORONER ARTER HASTALIKLI DİYABETİK OLGULARDA PRAVASTATİNİN İNFLAMATUVAR SÜREÇ ÜZERİNE ETKİLERİ (2020)
- PATHOPHYSIOLOGY, CLINICAL FEATURES AND TREATMENT OF MICROVASCULAR ANGINA: A REVIEW (2020)
- Assessment of right ventricular function in patients with pulmonary arterial hypertension-congenital heart disease and repaired and unrepaired defects: Correlation among speckle tracking, conventional echocardiography, and clinical parameters (2020)
- Cumulative non-HDL-cholesterol burden in patients with hypertriglyceridemia receiving long-term fibrate therapy: Real life data from a lipid clinic cohort (2020)
- Evaluation of the Effectiveness of the Theory Based Individual Counseling Initiative inPatients with Familial Hipercholesterolemia (2020)
- Impact of the COVID-19 pandemic in patients with a previous history of premature myocardial infarction (2020)
- Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia (2020)
- Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry) (2020)
- An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors (2020)
- Monozygotic twins with familial hypercholesterolemia and high lipoprotein(a) levels leading to identical cardiovascular outcomes: Case report and review of the literature (2020)
- Effect of Statin Therapy in Tpe-Interval and Tpe/Qtc Ratio in Patients with Familial Hypercholesterolemia (2020)
- Is gender an increasing factor of total ischemic time in patients withST elevation myocardial infarction? Analysis of TURKMI study (2019)
- Lipid Lowering Therapy Use In Secondary Prevention: An Analysis Of Ephesus Study (2019)
- Control and Management of Cardiovascular Disease in Turkey (2019)
- Expression Pattern of miRNAs in Patientswith Pulmonary Arterial Hypertension (2019)
- Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study (2019)
- Lipid profile, familial hypercholesterolemia prevalence, and 2-year cardiovascular outcome assessment in acute coronary syndrome: Real-life data of a retrospective cohort (2019)
- DATA ON SMOKING IN TURKEY: SYSTEMATIC REVIEW, META-ANALYSIS AND META-REGRESSION OF EPIDEMIOLOGICAL STUDIES ON CARDIOVASCULAR RISK FACTORS (2019)
- Cardiac amyloidosis: Recent advances in the diagnosis and therapy (2019)